This article discusses the tumor immune microenvironment (TIME) and its role in determining the effectiveness of immunotherapy. The authors highlight the complexity of the TIME and how it influences the response to immunotherapeutic interventions. They describe three main classes of TIME: infiltrated-excluded (I-E), infiltrated-inflamed (I-I), and tertiary lymphoid structure (TLS)-TIME. Each class has distinct characteristics that affect the tumor's response to immunotherapy. The study also explores how tumor genotypes and phenotypes interact with the TIME, influencing immune cell function and tumor progression. The authors emphasize the importance of understanding the TIME to improve immunotherapy outcomes and develop new therapeutic strategies. They also discuss the role of systemic factors, such as diet, exercise, and the microbiome, in shaping the TIME. The article concludes with future directions for research, including the use of advanced technologies to better characterize the TIME and improve immunotherapy.This article discusses the tumor immune microenvironment (TIME) and its role in determining the effectiveness of immunotherapy. The authors highlight the complexity of the TIME and how it influences the response to immunotherapeutic interventions. They describe three main classes of TIME: infiltrated-excluded (I-E), infiltrated-inflamed (I-I), and tertiary lymphoid structure (TLS)-TIME. Each class has distinct characteristics that affect the tumor's response to immunotherapy. The study also explores how tumor genotypes and phenotypes interact with the TIME, influencing immune cell function and tumor progression. The authors emphasize the importance of understanding the TIME to improve immunotherapy outcomes and develop new therapeutic strategies. They also discuss the role of systemic factors, such as diet, exercise, and the microbiome, in shaping the TIME. The article concludes with future directions for research, including the use of advanced technologies to better characterize the TIME and improve immunotherapy.